Clinical trial
Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status
NCT01916122 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 1, 2013
- Completion date
- April 3, 2024
- Enrollment
- 54 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer